Bank Of New York Mellon Corp Capricor Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$3.78 - $5.03 $319,776 - $425,522	84,597 New	84,597 $357 Million
Q4 2022 Feb 14, 2023	BUY	$3.36 - $6.55 $284,245 - $554,110	84,597 New	84,597 $326,000
Q2 2022 Aug 15, 2022	SELL	$2.89 - $4.51 $2,077 - $3,242	-719 Reduced 0.84%	84,656 $296,000
Q2 2021 Aug 11, 2021	SELL	$3.16 - $5.72 $4,395 - $7,956	-1,391 Reduced 1.6%	85,375 $437,000
Q1 2021 May 13, 2021	SELL	$3.63 - $7.93 $9,013 - $19,690	-2,483 Reduced 2.78%	86,766 $406,000
Q4 2020 Feb 09, 2021	BUY	$3.43 - $5.23 $98,814 - $150,671	28,809 Added 47.67%	89,249 $306,000
Q3 2020 Nov 12, 2020	BUY	$4.08 - $9.81 $246,595 - $592,916	60,440 New	60,440 $317,000

8.18M

1.78M

1.4M

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $334M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.